Berkeley Institute International

🌟 Some good news in the fight against cancer 🌟

While scary headlines about health can take over the news, there’s important progress happening behind the scenes. According to the 2025 Annual Report to the Nation, cancer death rates in the U.S. have been steadily decreasing for the last two decades—even during the pandemic.

📉 From 2018 to 2022, cancer death rates fell by an average of: ➡️ 1.7% per year for men
➡️ 1.3% per year for women

This is largely thanks to declines in lung cancer, breakthroughs in treatment, and greater access to healthcare through efforts like the Affordable Care Act.

But we still have work to do.

⚠️ Cancer rates are rising among women under 50.
⚠️ Racial disparities in outcomes remain deeply troubling.
⚠️ Weight-related cancers are on the rise.

So while the progress is worth celebrating, we need to stay focused on equity, prevention, and supporting caregivers—especially women, who now shoulder a growing cancer burden.

Let’s keep moving forward together.

Death Rate From Cancer Has Steadily Fallen in The US, Report Shows Bad health news has a way of taking over the headlines, and while there are many dangerous and debilitating diseases and infections on the rise, there is also great progress being made, year on year.

🚨 A groundbreaking step forward in brain cancer care.
Mayo Clinic researchers have unveiled a personalized blood test that could transform how doctors monitor high-grade gliomas—a particularly aggressive form of brain cancer.

Traditionally, clinicians rely on MRIs and biopsies to track tumor progression. But scans can be misleading, and biopsies are invasive.

This new approach uses a patient’s unique tumor DNA “fingerprint” to look for circulating tumor fragments in the blood—offering a faster, less invasive, and more precise way to detect cancer changes.

💡 In early trials, this test picked up changes before MRI scans did in some patients. That’s a potential game-changer for catching progression earlier and improving outcomes.

🔬 The research focuses on DNA junctions—special tumor-specific markers that help overcome the challenges of the brain’s protective blood-brain barrier.

🧬 “By tracking each tumor’s distinct molecular signature, we’re aiming to shift from a reactive approach to a proactive one,” says neurosurgeon Dr. Terry Burns.

🌟 While more research is needed, this innovation could pave the way for more personalized and responsive treatment for patients battling one of the toughest cancers.